Program

 Program as of 22 August 2018.

 

SATURDAY, 1st SEPTEMBER 2018

TIME

TOPIC

 SPEAKERS

08.00 - 17.00 

Registration Open

 

08.00 - 08.45

Arrival Tea & Coffee

 

08.45 - 09.00

Welcome and Outline of Program
Chairs: Jim Siderov & Gail Rowan

 

09.00 - 10.00










Lung Cancer Update
Chair: Jim Siderov

Oral agents targeted to EGFR and ALK and more recently immunotherapy started the change in lung cancer treatment, this update will expand on where these treatments are up to and are heading and new areas of treatment options.

Session sponsored by
MPL Logo 2col RGB

Paul Mitchell 

10.00 - 11.00











Colorectal Cancer Update
Chair: Jim Siderov

Many advances are happening in the optimal treatment of colorectal cancer, from the treatment of right sided v left sided tumours, length of adjuvant treatment, and the potential place of immune therapies in some CRC. This update will look at these and other new insights into CRC treatment.

Session sponsored by
AMG Onc Blu

Sophia Frentzas

11.00 - 11.15

Morning Tea

 

11.15 - 12.00






Multiple Myeloma Update
Chair: Michael Powell

For years this condition has been exploding with treatment options and an ever changing paradigm of care. In this session we will look at the current evidence for the multiple treatments available and their current place in therapy.

Myles Wright 

12.00 - 12.30

MASCC update
Chair: Michael Powell

 Jenny Casanova

12.30 - 13.30

Lunch

 

13.30 - 14.30










Breast Cancer Update
Chair: Jenny Casanova

The treatment options in breast cancer are ever evolving, in this update areas looked at will include; the role of and use of bisphosphonates in early BC, the rise of dose-density in early BC, and newer oral agents in metastatic disease and their complex toxicities.

Session sponsored by
Roche20

Belinda Yeo 

14.30 - 15.15











Biosimilars
Chair: Jenny Casanova

Biosimilars are coming! Whilst we are used to generic medications the use of biosimilars in cancer is relatively new with new agents on the horizon. This session will look at the clinical aspects of biosimilars, application of data between indications and pharmacovigilance aspects of their use.

Session sponsored by
BD

 David Liew 

15.15 - 15.30

Afternoon Tea

 

15.30 - 17.00









Parallel session: Acute Leukaemia (green dots)
Chair: Michael Powell


Management of acute leukaemia is a complex task, pharmacists require an understanding of complex concepts in diagnosis, treatment and management of disease and medication related complications. This interactive workshop will provide an update on current and emerging treatments for acute leukaemia in context of patient case studies illustrating issues relevant to the cancer pharmacist.

 Tara Cochrane & Michael Powell

15.30 - 17.00





Parallel session: Toxicities of Immunotherapy  (blue dots)
Chair: Jim Siderov

An interactive workshop type session that will take an in-depth look at the toxicity profiles of these groups of agents focussed on different toxicities and the growing knowledge about toxicity, complexity and treatment options.

Christine Carrington 

17.00 - 18.00



Welcome Drinks
Sponsored by

Roche20

 

 


SUNDAY, 2nd SEPTEMBER 2018

 TIME  TOPIC  SPEAKERS
08.15 - 15.15 Registration Open  
08.15 - 09.00 Arrival Tea & Coffee  
09.00 - 10.30








Professional development workshop
Chair: Gail Rowan

Pharmacists (especially experienced ones) are often called upon to teach and supervise others from pharmacists to students. This year’s professional development workshop will look at tools to help.

Session sponsored by
Baxter logo

 Gail Rowan
10.30 - 10.50 Morning Tea  

10.50 - 12.20






Head & Neck Cancer
Chair: Gail Rowan

Care of patients with Head & Neck cancer is often a complex mix of radiation therapy and medical oncology and can have complex support needs. This session will include insights from both radiation oncology and medical oncology and also how the pharmacists can add great value to the care of these patients.

Tsien Fua &
Sam Maleki
Muhammad Alamgeer

12.20 - 13.20  Lunch  

13.20 - 14.50


 

Anti-infectives Update
Chair: Gail Rowan

Infection continues to be a major concern in the treatment of cancer patients. This session will look at the emerging infectious complications with the advances in treatment options and help in understanding these.
 Ben Teh
14:50 - 15.00


Thanks & Close
Chairs: Jim Siderov & Gail Rowan